Cellularline S.p.A.
MIL:CELL.MI
2.78 (EUR) • At close April 22, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 158.648 | 137.644 | 110.575 | 104.54 | 140.44 | 93.827 | 160.37 | 159.374 | 156.533 | 154.541 | 0 |
| Cost of Revenue
| 110.864 | 84.218 | 62.363 | 59.615 | 75.824 | 46.327 | 67.298 | 66.055 | 136.324 | 103.724 | 0.006 |
| Gross Profit
| 47.784 | 53.426 | 48.212 | 44.925 | 64.616 | 47.5 | 93.072 | 93.319 | 20.209 | 50.817 | -0.006 |
| Gross Profit Ratio
| 0.301 | 0.388 | 0.436 | 0.43 | 0.46 | 0.506 | 0.58 | 0.586 | 0.129 | 0.329 | -245.846 |
| Reseach & Development Expenses
| 1.314 | 1.375 | 0 | 0 | 2.68 | 0.503 | 0.543 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 6.359 | 6.217 | 5.182 | 5.567 | 5.538 | 4.701 | 3.819 | 10.918 | 2.03 | 0 | 0 |
| Selling & Marketing Expenses
| 16.234 | 18.819 | 15.646 | 12.98 | 16.424 | 8.033 | 45.588 | 47.091 | 1.5 | 0 | 0 |
| SG&A
| 42.733 | 25.036 | 20.828 | 18.547 | 21.962 | 12.734 | 49.407 | 58.009 | 3.53 | 15.512 | 0 |
| Other Expenses
| -0.913 | 31.045 | 28.739 | 26.223 | 23.799 | 0.144 | 1.294 | 1.467 | -0.135 | 0 | 0 |
| Operating Expenses
| 43.646 | 56.081 | 49.567 | 44.77 | 45.761 | 27.045 | 58.048 | 58.009 | 3.665 | 29.624 | 0.273 |
| Operating Income
| 4.138 | -73.593 | 1.795 | 0.998 | 20.347 | 20.132 | 35.852 | 36.75 | 16.544 | 21.411 | -0.341 |
| Operating Income Ratio
| 0.026 | -0.535 | 0.016 | 0.01 | 0.145 | 0.215 | 0.224 | 0.231 | 0.106 | 0.139 | -13,127.692 |
| Total Other Income Expenses Net
| -0.148 | -1.223 | -8.351 | -3.394 | -0.265 | 5.648 | -1.647 | -4.298 | 1.087 | -4.726 | -0.292 |
| Income Before Tax
| 3.99 | -74.816 | -6.556 | -2.396 | 20.082 | 26.103 | 33.377 | 31.012 | 17.631 | 16.685 | -0.634 |
| Income Before Tax Ratio
| 0.025 | -0.544 | -0.059 | -0.023 | 0.143 | 0.278 | 0.208 | 0.195 | 0.113 | 0.108 | -24,369.308 |
| Income Tax Expense
| 0.655 | 0.349 | -2.71 | -16.297 | 1.874 | -6.275 | 9.572 | 9.321 | 8.416 | 8.66 | 0 |
| Net Income
| 3.595 | -75.165 | -3.846 | 13.9 | 18.209 | 32.378 | 23.805 | 21.691 | 9.215 | 8.025 | -0.634 |
| Net Income Ratio
| 0.023 | -0.546 | -0.035 | 0.133 | 0.13 | 0.345 | 0.148 | 0.136 | 0.059 | 0.052 | -24,369.308 |
| EPS
| 0.17 | -3.52 | -0.18 | 0.64 | 0.84 | 1.85 | -0.26 | 1.62 | 0.013 | 0.011 | 0 |
| EPS Diluted
| 0.17 | -3.52 | -0.18 | 0.64 | 0.84 | 1.8 | -0.26 | 1.62 | 0.013 | 0.011 | 0 |
| EBITDA
| 17.543 | 14.477 | 20.783 | 15.882 | 30.226 | 25.662 | 38.974 | 39.034 | 32.713 | 37.257 | -0.008 |
| EBITDA Ratio
| 0.111 | 0.105 | 0.188 | 0.152 | 0.215 | 0.274 | 0.243 | 0.245 | 0.209 | 0.241 | -293.231 |